End-of-day quote
Shanghai S.E.
06:00:00 2024-05-15 pm EDT
|
5-day change
|
1st Jan Change
|
35.44
CNY
|
-0.45%
|
|
-11.40%
|
-48.17%
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,618
|
18,612
|
9,209
|
4,773
|
-
|
Enterprise Value (EV)
1 |
3,618
|
18,612
|
9,209
|
4,773
|
4,773
|
P/E ratio
|
54.7
x
|
51.2
x
|
-263
x
|
20.1
x
|
16
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
8.06
x
|
-
|
6.74
x
|
2.36
x
|
1.97
x
|
EV / Revenue
|
8.06
x
|
-
|
6.74
x
|
2.36
x
|
1.97
x
|
EV / EBITDA
|
38,576,621
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.64
x
|
-
|
3.67
x
|
1.62
x
|
1.48
x
|
Nbr of stocks (in thousands)
|
121,520
|
121,823
|
134,673
|
134,673
|
-
|
Reference price
2 |
29.77
|
152.8
|
68.38
|
35.44
|
35.44
|
Announcement Date
|
2/25/20
|
2/20/23
|
4/23/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
448.9
|
-
|
1,366
|
2,025
|
2,421
|
EBITDA
|
93.78
|
-
|
-
|
-
|
-
|
EBIT
1 |
77.3
|
-
|
-53.2
|
257
|
321
|
Operating Margin
|
17.22%
|
-
|
-3.9%
|
12.69%
|
13.26%
|
Earnings before Tax (EBT)
1 |
76.97
|
-
|
-59.1
|
255
|
319
|
Net income
1 |
66.16
|
362.9
|
-33.21
|
236
|
298
|
Net margin
|
14.74%
|
-
|
-2.43%
|
11.65%
|
12.31%
|
EPS
2 |
0.5444
|
2.986
|
-0.2600
|
1.760
|
2.210
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/25/20
|
2/20/23
|
4/23/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
8.65%
|
-
|
-1.75%
|
8%
|
9.2%
|
ROA (Net income/ Total Assets)
|
7.23%
|
-
|
-
|
-
|
-
|
Assets
1 |
915.7
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
8.170
|
-
|
18.60
|
21.90
|
24.00
|
Cash Flow per Share
2 |
0.4800
|
-
|
0.2500
|
1.910
|
2.870
|
Capex
|
97.4
|
-
|
-
|
-
|
-
|
Capex / Sales
|
21.69%
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/25/20
|
2/20/23
|
4/23/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -48.17% | 664M | | +8.29% | 113B | | +10.21% | 106B | | +0.41% | 22.27B | | -11.90% | 22.22B | | -5.99% | 19.43B | | -37.36% | 17.87B | | -5.17% | 17.24B | | +7.70% | 14.29B | | +37.65% | 12.52B |
Bio Therapeutic Drugs
|